A patient trying to heal from an injury still needs a proper diagnosis, appropriate rehabilitation, progressive loading, adequate protein, sleep, hydration, metabolic support, and realistic timelines
However, Epithalon remains investigational with no FDA approval, most research conducted in Russia with limited Western replication, long-term human safety data sparse, optimal dosing protocols still debated, and mechanisms not fully understood
The 15% glucose improvement from morning dosing in that small crossover trial is real but modest
Commercial Electronic Message: I agree to receive Commercial Electronic Messages from Private Anadolu Medical Center Hospital and Private Anadolu Health Ataehir Medical Center for all kinds of health-related information, promotions, openings, invitations, event reminders, and communication activities.
Originally published by Harvard Health
Low incidences of seizures have been reported with oral doses in individuals with or without preexisting seizure disorders